Integrated DNA Technologies Expands European Production Capabilities
IDT's growth enables faster shipping, broader reach, and expanded European product portfolio
Integrated DNA Technologies (IDT) has announced the completion of its newly-expanded European facility in the Haasrode Research Park area of Leuven, Belgium. The 2000m2 state-of-the-art production facility enables IDT to provide an even more effective service for its growing number of customers in Europe, the Middle-East, and Africa. These same customers will also benefit from improved access to IDT's global product portfolio.
Bonnie Barney, Sr VP European Sales & Marketing for IDT, commented, "With over 20 employees and the capability to produce around 4000 oligos daily at our European facility, we are now able to provide our customers with a very fast service, excellent support, and a fuller range of IDT's products - all from right here in Europe. While growing our manufacturing capacity, we have also expanded our direct sales force in the United Kingdom, Ireland, and the Benelux countries, along with our representation through distributors in Spain, Italy, Norway, Hungary, Turkey, Poland, Israel and South Africa."
Topics
Organizations
Other news from the department manufacturing

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents

How CRISPR can help fight against neurodegenerative diseases - Scientists listed ways of applying genetic engineering to treat Parkinson's disease

Stem Cells May Speed Up Screening of Drugs for Rare Cancers

AiCuris and Hybridize Therapeutics enter worldwide license agreement of up to €100M for a direct-acting RNA-based therapy against BK Virus
Removab Approval: Proof-of-Concept for Technology Transfer in Germany

Decoding Blood Platelet Production: The Intricate Role of Lipids - Disruptions in lipid metabolism might affect platelet production

Excessive fluid consumption: habit or hormonal disorder? - Which test provides a reliable diagnosis?

Molecular switch may serve as new target point for cancer and diabetes therapies
HIV/AIDS long-term costs high - and unaffordable to most-affected countries
Part of hagfish slime mystery solved

Effects of chemical mixtures: Neurotoxic effects add up - Study demonstrates for the first time the toxicological relevance of chemical mixtures as they occur in humans

Innovative approach to treat autism spectrum disorders - University of Basel spin-off Translation-X receives Venture Kick funding
